Revolution Medicines Claimed Company

REVOLUTION Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists. read more

EMPLOYEE PARTICIPANTS: 67

TOTAL RATINGS: 1413

CEO: Mark Goldsmith

HR or Marketing? Claim Your Free Employer Account

Mark Goldsmith Revolution Medicines CEO Rating

Revolution Medicines' CEO, Mark Goldsmith, has 75 employee ratings and a score of 93/100, placing them in the Top 5% of similar size companies on Comparably with 11-50 Employees and Top 5% of other companies in San Francisco. When breaking the CEO score down by factors such as department, gender, and ethnicity, we see that females at Revolution Medicines rate Mark Goldsmith higher than males, giving the CEO a score of 97/100.

Last updated months ago.

Where This Score Ranks Revolution Medicines' CEO Rating

TOP
5%
In the Top 5% of 2054 Similar Sized Companies on Comparably
TOP
5%
In the Top 5% of 932 Nearby Companies in San Francisco
1st
1st place versus 2 competitors rated on Comparably

Nov

Feb

Mar

Aug

Feb

A+93 / 100

Jan

Revolution Medicines CEO Mark Goldsmith Bio

Mark Goldsmith serves as the CEO / President of Revolution Medicines.

Who Ranks Revolution Medicines' CEO Rating the Highest?

Department - Communications 100/100

Department - Operations 99/100

Experience - 6 to 10 Years 99/100

Who Ranks Revolution Medicines' CEO Rating the Lowest?

Experience - 1 to 3 Years 83/100

Experience - 3 to 6 Years 83/100

Gender - Male 91/100

Revolution Medicines CEO Mark Goldsmith At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Revolution Medicines.

Based on 75 ratings, Mark Goldsmith ranks right above Denali Therapeutics' CEO, Ryan Watts.

Revolution Medicines' CEO is highly regarded by the Communications department, the Operations department, and employees with 6 to 10 Years experience. However, employees with 1 to 3 Years experience, employees with 3 to 6 Years experience, and Male employees have a less favorable view of the CEO and believe there is room for improvement. Overall, the CEO score has remained stable over the last 90 days.